BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3113273)

  • 1. The economic costs of Alzheimer's disease.
    Hay JW; Ernst RL
    Am J Public Health; 1987 Sep; 77(9):1169-75. PubMed ID: 3113273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US economic and social costs of Alzheimer's disease revisited.
    Ernst RL; Hay JW
    Am J Public Health; 1994 Aug; 84(8):1261-4. PubMed ID: 8059882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic considerations in Alzheimer's disease.
    Meek PD; McKeithan K; Schumock GT
    Pharmacotherapy; 1998; 18(2 Pt 2):68-73; discussion 79-82. PubMed ID: 9543467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the family cost of private nursing home care versus home care for patients with dementia in Taiwan.
    Chiu L; Shyu WC
    Chang Gung Med J; 2001 Oct; 24(10):608-14. PubMed ID: 11771182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs: measuring the economic burden of Alzheimer's disease care.
    J Nurs Adm; 1997 Jan; 27(1):4. PubMed ID: 9006594
    [No Abstract]   [Full Text] [Related]  

  • 6. The Potential Impact of Alzheimer's Disease Early Treatment on Societal Costs of Care in Czechia: A Simulation Approach.
    Broulikova HM; Sladek V; Arltova M; Cerny J
    J Ment Health Policy Econ; 2018 Dec; 21(4):147-161. PubMed ID: 30676992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted economic damage from a quick, simple Alzheimer's disease cure.
    Norins LC
    Med Hypotheses; 2019 Dec; 133():109398. PubMed ID: 31539811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model.
    McDonnell J; Redekop WK; van der Roer N; Goes E; Ruitenberg A; Busschbach JJ; Breteler MM; Rutten FF
    Pharmacoeconomics; 2001; 19(4):379-90. PubMed ID: 11383754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.
    Deb A; Thornton JD; Sambamoorthi U; Innes K
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Burden of Alzheimer's Disease Dementia in Japan.
    Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
    J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare for people with Alzheimer's disease.
    Fried L
    Issue Brief Cent Medicare Educ; 2004; 5(8):1-6. PubMed ID: 15580711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic impact of the tacrine in the treatment of Alzheimer's disease.
    Henke CJ; Burchmore MJ
    Clin Ther; 1997; 19(2):330-45. PubMed ID: 9152571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2016 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2016 Apr; 12(4):459-509. PubMed ID: 27570871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.
    Marešová P; Zahálková V
    Neurol Sci; 2016 Dec; 37(12):1917-1922. PubMed ID: 27470305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Annual economic cost of informal care in Alzheimer's disease].
    Turró-Garriga O; López-Pousa S; Vilalta-Franch J; Turon-Estrada A; Pericot-Nierga I; Lozano-Gallego M; Hernández-Ferràndiz M; Soler-Cors O; Planas-Pujol X; Monserrat-Vila S; Garre-Olmo J
    Rev Neurol; 2010 Aug; 51(4):201-7. PubMed ID: 20648463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of Alzheimer's disease care.
    Rice DP; Fox PJ; Max W; Webber PA; Lindeman DA; Hauck WW; Segura E
    Health Aff (Millwood); 1993; 12(2):164-76. PubMed ID: 8375811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public-private solution to protection against the cost of long-term care.
    Ball RM
    J Am Geriatr Soc; 1990 Feb; 38(2):156-63. PubMed ID: 2105349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How relevant are social costs in economic evaluations? The case of Alzheimer's disease.
    Peña-Longobardo LM; Rodríguez-Sánchez B; Oliva-Moreno J; Aranda-Reneo I; López-Bastida J
    Eur J Health Econ; 2019 Nov; 20(8):1207-1236. PubMed ID: 31342208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort.
    Welch HG; Walsh JS; Larson EB
    J Am Geriatr Soc; 1992 Mar; 40(3):221-4. PubMed ID: 1538039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving toward Medicare home health coverage for persons with Alzheimer's disease.
    Cabin WD
    J Gerontol Soc Work; 2008; 51(1-2):77-86. PubMed ID: 18826069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.